	Implementing palliative care in hepatocellular carcinoma ambulatory clinics-study protocol for Accelerated translational research in PRImary liver CAncer (APRICA) randomised controlled palliative care trial. Trials Gofton C, Di Bartolomeo A, Boutros R, Zurynski YA, Stafford-Bell F, Caldwell K, McCaughan G, Zekry A, Strasser SI, Levy M, Sheehan C, Goodall S, Davis JM, Sheahan L, Liu K, Greenaway S, Davison S, Du Huynh T, Quadri Z, Agar M, George J. PMID: 39506822 [PubMed - indexed for MEDLINE]
	Racial and Ethnic Differences in Liver Transplantation and Post-Liver Transplant Survival Among Patients With Hepatocellular Carcinoma. Cancer Med Grewal US, Chandar AK, Gaddam SJ, Al Armashi AR, Alkreshi A, Garikipati SC. PMID: 39506367 [PubMed - indexed for MEDLINE]
	FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis. Sci Rep Zeng Z, Xu S, Wang R, Han X. PMID: 39505995 [PubMed - indexed for MEDLINE]
	A pan-cancer study of ADAM9's immunological function and prognostic value particularly in liver cancer. Sci Rep AmeliMojarad M, AmeliMojarad M, Wang J, Tavakolpour V, Shariati P. PMID: 39505907 [PubMed - indexed for MEDLINE]
	Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis. JAMA Netw Open Ilagan-Ying YC, Gordon KS, Tate JP, Lim JK, Torgersen J, Lo Re V 3rd, Justice AC, Taddei TH. PMID: 39504020 [PubMed - indexed for MEDLINE]
	Impact of IL-8 on survival after TARE in HCC: a comprehensive investigation and external validation from the SORAMIC trial. J Cancer Res Clin Oncol Schindler A, Fischer J, Beeskow AB, Lincke T, Ebel S, Seehofer D, Denecke T, Veelken R, Sabri O, Öcal O, Seidensticker M, Berg T, van Bömmel F. PMID: 39503874 [PubMed - indexed for MEDLINE]
	Comprehensive evaluation of clinical outcomes in hepatic epithelioid hemangioendothelioma subsets: insights from SEER Database and departmental cohort analysis. Front Immunol Wang B, Chen X, Li R, Ai B, Ye F, Zhao J, Zhang Y, Huang Z, Li Z, Bi X, Zhao H, Cao D, Cai J, Zhou J, Yan T. PMID: 39502705 [PubMed - indexed for MEDLINE]
	The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions. Front Immunol Ning J, Wang Y, Tao Z. PMID: 39502703 [PubMed - indexed for MEDLINE]
	Safety and efficacy of DEB-TACE in combination with lenvatinib and camrelizumab for the treatment of unresectable hepatocellular carcinoma (uHCC): a two-centre retrospective study. Front Immunol Xuexian Z, Ruidong W, Yuhan D, Qingwei L, Feng X, Hong R, Jun Z, Wei L. PMID: 39502690 [PubMed - indexed for MEDLINE]
	Development and Validation of a Blood-Biomarker-Based Predictive Model for HBV-Associated Hepatocellular Carcinoma. Clin Appl Thromb Hemost Tan Y, Xia W, Sun F, Mei B, Ouyang Y, Li L, Chen Z, Wu S, Tan J, Pubu Z, Sang B, Jiang T. PMID: 39501728 [PubMed - indexed for MEDLINE]
	Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study. BMJ Open Kowada A. PMID: 39500609 [PubMed - indexed for MEDLINE]
	Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study. Cancer Immunol Immunother Meng L, Li H, Ji Y, Yu P, Wang Z, Cao L, Shi B, Shao Y, Yan J, Gao Y, Zhu Z. PMID: 39499356 [PubMed - indexed for MEDLINE]
	Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study. Radiology Jiang H, Cannella R, Wu Z, Beaufrère A, Dioguardi Burgio M, Sartoris R, Wang Y, Qin Y, Chen J, Chen Y, Chen W, Shi Y, Song B, Ronot M. PMID: 39499179 [PubMed - indexed for MEDLINE]
	A case of mistaken identity: Gallstone-induced hepatic abscess mimicking metastasis. Ulus Travma Acil Cerrahi Derg Kamburo, Buzkan , Muhtaroglu A, Akdeniz Y, Altintoprak F. PMID: 39498707 [PubMed - indexed for MEDLINE]
	Clinical outcomes of modified transarterial chemoembolization vs. drug-eluting bead transarterial chemoembolization as initial treatment for single hepatocellular carcinoma: a propensity score matching analysis. Ann Med Chang B, Zhou C, Liu C, Mu L, Huang M, Bai M. PMID: 39498531 [PubMed - indexed for MEDLINE]
	The role of exosomes in liver cancer: comprehensive insights from biological function to therapeutic applications. Front Immunol Zhang Y, Zhang C, Wu N, Feng Y, Wang J, Ma L, Chen Y. PMID: 39497820 [PubMed - indexed for MEDLINE]
	DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases. Clin Epigenetics Dra, Rankovi, Zidar N, Hauptman N. PMID: 39497215 [PubMed - indexed for MEDLINE]
	A deep learning framework for hepatocellular carcinoma diagnosis using MS1 data. Sci Rep Xu W, Zhang L, Qian X, Sun N, Tu X, Zhou D, Zheng X, Chen J, Xie Z, He T, Qu S, Wang Y, Yang K, Su K, Feng S, Ju B. PMID: 39496730 [PubMed - indexed for MEDLINE]
	Gadoxetic acid-enhanced MRI for the detection of liver metastases from melanoma. PLoS One Chung HJ, Seo N, Han K, Bae H, Chung YE, Jung M, Park MS. PMID: 39495777 [PubMed - indexed for MEDLINE]
	Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort. Hepatol Commun de Castro T, Welland S, Jochheim L, Leyh C, Shmanko K, Finkelmeier F, Jeliazkova P, Jefremow A, Gonzalez-Carmona MA, Kandulski A, Roessler D, Ben Khaled N, Enssle S, Venerito M, Fründt TW, Schultheiß M, Djanani A, Pangerl M, Maieron A, Wirth TC, Marquardt JU, Greil R, Fricke C, Günther R, Schmiderer A, Bettinger D, Wege H, Scheiner B, Müller M, Strassburg CP, Siebler J, Ehmer U, Waidmann O, Weinmann A, Pinter M, Lange CM, Saborowski A, Vogel A. PMID: 39495153 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 69913

Page 1 of 3496



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy